Return to search results
Irbesartan
Irbesartan is a generic prescription medication used to treat high blood pressure and certain kidney problems in people with type 2 diabetes. It works by relaxing blood vessels as an angiotensin 2 receptor blocker. Available in 75mg, 150mg, and 300mg oral tablets from Aurobindo Pharma Ltd. (ANDA203081). This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Irbesartan is a generic prescription medication used to treat high blood pressure and certain kidney problems in people with type 2 diabetes. It works by relaxing blood vessels as an angiotensin 2 receptor blocker. Available in 75mg, 150mg, and 300mg oral tablets from Aurobindo Pharma Ltd. (ANDA203081). This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Irbesartan",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Irbesartan — ANDA 204740 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204740"
}
]
|
| identifier | ANDA204740 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-safety",
"health-care",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Irbesartan |
